Cargando…
Docosahexaenoic Acid Increases the Potency of Soluble Epoxide Hydrolase Inhibitor in Alleviating Streptozotocin-Induced Alzheimer’s Disease-Like Complications of Diabetes
Diabetes is a risk factor for Alzheimer’s disease and it is associated with significant memory loss. In the present study, we hypothesized that the soluble epoxide hydrolase (sEH) inhibitor N-[1-(1-oxopropyl)-4-piperidinyl]-N’-[4-(trifluoromethoxy)phenyl)-urea (also known as TPPU) could alleviate di...
Autores principales: | Pardeshi, Rohit, Bolshette, Nityanand, Gadhave, Kundlik, Arfeen, Mohammad, Ahmed, Sahabuddin, Jamwal, Rohitash, Hammock, Bruce D., Lahkar, Mangala, Goswami, Sumanta Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491817/ https://www.ncbi.nlm.nih.gov/pubmed/31068802 http://dx.doi.org/10.3389/fphar.2019.00288 |
Ejemplares similares
-
The ubiquitin proteasomal system: a potential target for the management of Alzheimer's disease
por: Gadhave, Kundlik, et al.
Publicado: (2016) -
Impact of diabetes on male sexual function in streptozotocin-induced diabetic rats: Protective role of soluble epoxide hydrolase inhibitor
por: Minaz, Nathani, et al.
Publicado: (2019) -
Design and Potency of Dual Soluble Epoxide Hydrolase/Fatty
Acid Amide Hydrolase Inhibitors
por: Kodani, Sean D., et al.
Publicado: (2018) -
Soluble Epoxide Hydrolase in Atherosclerosis
por: Wang, Yi-Xin Jim, et al.
Publicado: (2010) -
Bioactivation of leukotoxins to their toxic diols by epoxide hydrolase
por: Moghaddam, Mehran F., et al.
Publicado: (1997)